Escitalopram Found More Effective Than Prozac in Relapse Prevention, Analysis Shows
A large analysis has found that escitalopram, a widely prescribed antidepressant, outperformed Prozac in preventing relapse among many patients, adding fresh evidence to the debate over long-term treatment choices in major depressive disorder. The findings are likely to influence prescribing decisions as clinicians weigh efficacy, tolerability, and continuity of care for patients at high risk of recurrence.
